These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21122603)

  • 1. Effect of first-trimester ultrasound screening for Down syndrome on maternal-fetal attachment--a randomized controlled trial.
    Georgsson Öhman S; Waldenström U
    Sex Reprod Healthc; 2010 Aug; 1(3):85-90. PubMed ID: 21122603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nuchal and detailed morphology ultrasound examinations in early pregnancy for fetal structural abnormality screening: a randomized controlled trial.
    Chen M; Lee CP; Lam YH; Tang RY; Chan BC; Wong SF; Tse LH; Tang MH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):136-46; discussion 146. PubMed ID: 18254132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What about informed consent in first-trimester ultrasound screening for Down syndrome?
    Favre R; Moutel G; Duchange N; Vayssière C; Kohler M; Bouffet N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Nisand I
    Fetal Diagn Ther; 2008; 23(3):173-84. PubMed ID: 18417975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
    Saltvedt S; Almström H; Kublickas M; Valentin L; Bottinga R; Bui TH; Cederholm M; Conner P; Dannberg B; Malcus P; Marsk A; Grunewald C
    Ultrasound Obstet Gynecol; 2005 Jun; 25(6):537-45. PubMed ID: 15912479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening.
    Georgsson Ohman S; Saltvedt S; Grunewald C; Waldenström U
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):634-40. PubMed ID: 15225187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ultrasound in screening for fetal Down syndrome.
    Egan JF
    Curr Womens Health Rep; 2002 Feb; 2(1):52-8. PubMed ID: 12112983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population.
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialard F; Giudicelli Y; Ville Y
    Am J Obstet Gynecol; 2006 Nov; 195(5):1379-87. PubMed ID: 16723105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth of maternal-fetal emotional attachment in pregnant adolescents: a prospective cohort study.
    Rowe HJ; Wynter KH; Steele A; Fisher JR; Quinlivan JA
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):327-33. PubMed ID: 24075091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results.
    Chueh HY; Cheng PJ; Shaw SW; Lin CT; Hsu JJ; Hsieh TT
    Acta Obstet Gynecol Scand; 2007; 86(12):1437-41. PubMed ID: 17851819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [THE IMPACT OF 3D ULTRASOUND ON MATERNAL-FETAL BONDING DURING THE FETAL ANOMALY SCAN IN THE FIRST AND SECOND TRIMESTER].
    Pavlova E; Markov D; Ivanov S
    Akush Ginekol (Sofiia); 2015; 54(4):18-28. PubMed ID: 26410944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome screening using first-trimester combined tests and contingent use of femur length at routine anomaly scan.
    Salomon LJ; Chevret S; Bussieres L; Ville Y; Rozenberg P
    Prenat Diagn; 2010 Aug; 30(8):783-9. PubMed ID: 20575148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.